nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR3—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0521	0.0562	CbGpPWpGaD
Pasireotide—SSTR1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.05	0.0539	CbGpPWpGaD
Pasireotide—SSTR5—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0443	0.0478	CbGpPWpGaD
Pasireotide—SSTR2—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0409	0.0441	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0347	0.0374	CbGpPWpGaD
Pasireotide—SSTR3—Peptide GPCRs—TSHR—adrenal gland cancer	0.0278	0.03	CbGpPWpGaD
Pasireotide—SSTR1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0267	0.0288	CbGpPWpGaD
Pasireotide—SSTR5—Peptide GPCRs—TSHR—adrenal gland cancer	0.0237	0.0255	CbGpPWpGaD
Pasireotide—SSTR2—Peptide GPCRs—TSHR—adrenal gland cancer	0.0218	0.0236	CbGpPWpGaD
Pasireotide—SSTR5—pituitary gland—adrenal gland cancer	0.0205	0.298	CbGeAlD
Pasireotide—SSTR3—pituitary gland—adrenal gland cancer	0.0197	0.285	CbGeAlD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0164	0.0177	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0158	0.017	CbGpPWpGaD
Pasireotide—SSTR1—pituitary gland—adrenal gland cancer	0.0156	0.226	CbGeAlD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.014	0.0151	CbGpPWpGaD
Pasireotide—SSTR2—pituitary gland—adrenal gland cancer	0.0132	0.192	CbGeAlD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0129	0.0139	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0125	0.0135	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.012	0.0129	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0107	0.0115	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0105	0.0114	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00985	0.0106	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00983	0.0106	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00945	0.0102	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00878	0.00947	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00863	0.00931	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00842	0.00908	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00838	0.00903	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00773	0.00834	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0075	0.00809	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00747	0.00805	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00719	0.00776	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00708	0.00763	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00689	0.00743	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00679	0.00732	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00669	0.00721	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00643	0.00693	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00643	0.00693	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00641	0.00691	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00638	0.00688	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00616	0.00664	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00616	0.00664	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00602	0.00649	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00589	0.00635	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00569	0.00613	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00555	0.00599	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00547	0.00589	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00546	0.00589	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00525	0.00566	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00513	0.00553	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00504	0.00544	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00504	0.00544	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00492	0.0053	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00436	0.0047	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00433	0.00466	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00424	0.00457	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00415	0.00447	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00411	0.00443	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00407	0.00438	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00402	0.00434	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00389	0.00419	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00385	0.00415	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GNRHR—adrenal gland cancer	0.0038	0.00409	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00378	0.00407	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00373	0.00402	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00369	0.00398	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00368	0.00397	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00364	0.00393	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00362	0.00391	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00361	0.00389	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00353	0.00381	CbGpPWpGaD
Pasireotide—Desmopressin—PTGS2—adrenal gland cancer	0.00349	1	CrCbGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00344	0.00371	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00343	0.0037	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0034	0.00366	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00338	0.00365	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00336	0.00363	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00333	0.00359	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00332	0.00358	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00331	0.00357	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0033	0.00356	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00329	0.00355	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00327	0.00353	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00323	0.00348	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00321	0.00346	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00318	0.00343	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00305	0.00329	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00302	0.00326	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.003	0.00324	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00298	0.00321	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00297	0.0032	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00292	0.00315	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00292	0.00315	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00282	0.00304	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00277	0.00299	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0027	0.00291	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00269	0.0029	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—POMC—adrenal gland cancer	0.00262	0.00282	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0026	0.00281	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00251	0.00271	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00246	0.00266	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00236	0.00255	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0023	0.00248	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00227	0.00245	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—POMC—adrenal gland cancer	0.00223	0.0024	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00221	0.00238	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0022	0.00237	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00218	0.00235	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00211	0.00227	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00209	0.00226	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00209	0.00225	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00208	0.00224	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—POMC—adrenal gland cancer	0.00206	0.00222	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSHR—adrenal gland cancer	0.00203	0.00219	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.002	0.00216	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—GNAS—adrenal gland cancer	0.002	0.00215	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00199	0.00215	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00196	0.00211	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSHR—adrenal gland cancer	0.00194	0.0021	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00193	0.00209	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00193	0.00208	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00191	0.00206	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MEN1—adrenal gland cancer	0.00191	0.00206	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00187	0.00202	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00183	0.00197	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00181	0.00195	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00179	0.00192	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00178	0.00192	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00177	0.00191	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00173	0.00186	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSHR—adrenal gland cancer	0.00172	0.00186	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—GNAS—adrenal gland cancer	0.0017	0.00183	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00164	0.00177	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00163	0.00176	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MEN1—adrenal gland cancer	0.00162	0.00175	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSHR—adrenal gland cancer	0.00159	0.00172	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00157	0.00169	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MEN1—adrenal gland cancer	0.0015	0.00161	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—POMC—adrenal gland cancer	0.00148	0.0016	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00146	0.00157	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00142	0.00153	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.0014	0.0015	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—POMC—adrenal gland cancer	0.00134	0.00145	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—POMC—adrenal gland cancer	0.00129	0.00139	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00126	0.00136	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00124	0.00133	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDC42—adrenal gland cancer	0.00123	0.00133	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF2—adrenal gland cancer	0.00119	0.00128	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDC42—adrenal gland cancer	0.00118	0.00128	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GNAS—adrenal gland cancer	0.00118	0.00127	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—POMC—adrenal gland cancer	0.00116	0.00125	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF1R—adrenal gland cancer	0.00115	0.00124	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—POMC—adrenal gland cancer	0.00114	0.00123	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00114	0.00123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF2—adrenal gland cancer	0.00114	0.00123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—GNAS—adrenal gland cancer	0.00113	0.00122	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.0011	0.00119	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—adrenal gland cancer	0.00105	0.00114	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDC42—adrenal gland cancer	0.00105	0.00113	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF2—adrenal gland cancer	0.00101	0.00109	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GNAS—adrenal gland cancer	0.001	0.00108	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TERT—adrenal gland cancer	0.00099	0.00107	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000978	0.00105	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDC42—adrenal gland cancer	0.000969	0.00104	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TERT—adrenal gland cancer	0.000949	0.00102	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF2—adrenal gland cancer	0.000934	0.00101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GNAS—adrenal gland cancer	0.000926	0.000998	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000903	0.000973	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BAD—adrenal gland cancer	0.000861	0.000929	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TERT—adrenal gland cancer	0.000842	0.000908	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BAD—adrenal gland cancer	0.000826	0.00089	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—adrenal gland cancer	0.000794	0.000856	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BRAF—adrenal gland cancer	0.000784	0.000845	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TERT—adrenal gland cancer	0.000777	0.000838	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—adrenal gland cancer	0.000761	0.000821	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—adrenal gland cancer	0.00076	0.000819	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000752	0.000811	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BAD—adrenal gland cancer	0.000732	0.00079	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000729	0.000786	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BAD—adrenal gland cancer	0.000676	0.000729	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—adrenal gland cancer	0.000675	0.000728	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BRAF—adrenal gland cancer	0.000667	0.000719	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000646	0.000697	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—adrenal gland cancer	0.000623	0.000672	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BRAF—adrenal gland cancer	0.000615	0.000663	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000596	0.000643	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000567	0.000611	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000543	0.000586	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000482	0.00052	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—adrenal gland cancer	0.000449	0.000484	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000445	0.000479	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—adrenal gland cancer	0.00043	0.000464	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—adrenal gland cancer	0.000382	0.000412	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—adrenal gland cancer	0.000377	0.000406	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—adrenal gland cancer	0.000361	0.00039	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—adrenal gland cancer	0.000352	0.00038	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—adrenal gland cancer	0.000321	0.000346	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—adrenal gland cancer	0.000296	0.000319	CbGpPWpGaD
